To evaluate the therapeutic potential of CD10‐OGP signals in vivo, we adopted a xenograft mouse model by coinjecting human CAFs and breast cancer cells into the mammary fat pads of immunocompromised mice, as previously described.[25] Mice were administered chemotherapy after the tumors were palpable. The gene discussed is OVGP1; the disease is breast cancer.